XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of performance-based awards

Period Granted

Options Granted

RSUs Granted

Options Vested

RSUs Vested

Milestone

Valuation Method

(in thousands)

Q1 2019

200

300

169

260

(1)

Monte-Carlo Simulation

Q2 2019

188

81

(2)

Fair Market Value

Q3 2019

50

38

(1)

Monte-Carlo Simulation

Q1 2020

150

300

94

216

(1)

Monte-Carlo Simulation

Q1 2020

436

404

(3)

Fair Market Value

Q1 2020

129

129

(3)

Black-Scholes-Merton

Q2 2020

21

21

(3)

Fair Market Value

Q3 2020

10

10

(4)

Black-Scholes-Merton

Q3 2020

27

13

(3)

Fair Market Value

Q4 2020

32

6

(1)

Monte-Carlo Simulation

Q4 2020

22

2

(5)

Fair Market Value

Q1 2021

150

125

(1)

Monte-Carlo Simulation

Q1 2021

279

10

(3)

Fair Market Value

Q2 2021

163

(1)

Monte-Carlo Simulation

Q2 2021

29

(3)

Black-Scholes-Merton

Q2 2021

7

(3)

Fair Market Value

________________________________

(1) The awards will vest based on the achievement of certain values of the Company’s common stock at multiple thresholds within certain periods and are contingent upon the completion of requisite service through the date of such vesting.

(2) The vesting of the awards will be triggered after the end of the achievement milestone, as measured by the Company.

(3) The awards will vest based on achievement of a revenue target and are contingent upon the completion of requisite service through the date of such vesting.

(4) The awards vest based on achievement of a reimbursement target.


(5) The awards will vest based on achievement of certain revenue and recruiting targets.

Summary of stock option activity

Outstanding Options

    

    

    

    

Weighted-

    

Weighted-

Average

Shares

Average

Remaining

Aggregate

Available for

Number of

Exercise

Contractual

Intrinsic

(in thousands, except for contractual life and exercise price)

Grant

Shares

Price

Life

Value

(in years)

Balance at December 31, 2020

 

3,197

 

6,707

$

11.19

6.04

$

592,468

Additional shares authorized

 

3,446

Options granted

 

(390)

 

390

$

104.01

Options exercised

 

 

(782)

$

8.73

Options forfeited/cancelled

 

31

 

(31)

$

13.80

RSUs granted

(1,355)

RSUs forfeited/cancelled

164

Balance at June 30, 2021

 

5,093

 

6,284

$

17.25

5.93

$

605,986

Exercisable at June 30, 2021

 

4,823

$

9.93

5.23

$

499,683

Vested and expected to vest at June 30, 2021

 

6,194

$

16.90

5.90

$

599,432

Restricted stock units

Weighted-

Average

Grant Date

(in thousands, except for grant date fair value)

Shares

Fair Value

Balance at December 31, 2020

4,188

$

34.02

Granted

1,355

$

103.67

Vested

(1,387)

$

26.50

Cancelled/forfeited

(164)

$

41.33

Balance at June 30, 2021

3,992

$

59.73

Summary of stock-based compensation expenses

Three months ended June 30, 

2021

2020

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

(in thousands)

Cost of revenues

$

1,275

$

$

1,275

$

441

$

$

441

Research and development

 

6,276

 

340

 

6,616

 

2,631

 

282

 

2,913

Selling, general and administrative

 

27,146

 

66

 

27,212

 

8,527

 

76

 

8,603

Total

$

34,697

$

406

$

35,103

$

11,599

$

358

$

11,957

Six months ended June 30, 

 

2021

2020

 

    

Employee

    

Non-Employee

    

Total

    

Employee

    

Non-Employee

    

Total

 

 

(in thousands)

Cost of revenues

$

1,983

$

$

1,983

$

755

$

$

755

Research and development

 

9,926

 

564

 

10,490

 

4,313

 

442

 

4,755

Selling, general and administrative

 

45,751

 

111

 

45,862

 

13,779

 

85

 

13,864

Total

$

57,660

$

675

$

58,335

$

18,847

$

527

$

19,374

Performance-based awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

June 30, 

2021

Risk-free interest rate

0.80

%

1.42

%

Expected dividend yield

0.00

%

Expected volatility

60

%

Expected term (years)

7.25

10.00

Employee stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of assumptions used in valuation of fair value

Three months ended June 30, 

Six months ended June 30, 

    

2021

    

    

2020

    

2021

2020

Expected term (years)

 

5.11

10.00

 

10.00

5.11

10.00

5.27

10.00

Expected volatility

 

56.01

%

63.30

%

 

53.94

%

55.33

%

63.30

%

49.94

%

58.53

%

Expected dividend rate

 

0.00

%

 

0.00

%

0.00

%

0.00

%

Risk-free interest rate

 

0.81

%

1.67

%

 

0.71

%

0.81

%

1.67

%

0.44

%

1.70

%